TinyHLAnet: A Light-Weight 3D Structure-Aware Architecture for Rapid and Explainable Identification of CD8+ T-Cell Antigens

IF 4.1 4区 医学 Q2 CELL BIOLOGY
HLA Pub Date : 2025-10-03 DOI:10.1111/tan.70410
Naren Chandran Sakthivel, Sumanta Mukherjee, Nagasuma Chandra
{"title":"TinyHLAnet: A Light-Weight 3D Structure-Aware Architecture for Rapid and Explainable Identification of CD8+ T-Cell Antigens","authors":"Naren Chandran Sakthivel,&nbsp;Sumanta Mukherjee,&nbsp;Nagasuma Chandra","doi":"10.1111/tan.70410","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>CD8+ T cell response is contingent on the surveillance and recognition of peptide antigens presented on HLA class I molecules. The highly polymorphic nature of the HLA loci combined with the vast cognate peptide space makes comprehensive experimental characterisation of the peptides presented by different individuals in different disease conditions intractable. Several computational methods for epitope prediction exist, but there is a necessity in the field for rapid, interpretable and personalised prediction of CD8+ T cell epitopes. We address this gap by developing a novel deep learning architecture, termed TinyHLAnet, that produces highly accurate and fast prediction of peptide-HLA (class I) complex formation. This architecture is developed using constraints derived from domain knowledge of contact formation in peptide-HLA (class I) complexes. Specifically, the estimation of binding affinity of the peptide-HLA complex is decomposed into subproblems relating to estimating the interaction strength of each intermolecular residue pair in the complex, which in itself is factorised into three different components based on knowledge of residue pair interactions. This compartmentalisation allows for the production of a model that uses a fraction of the parameters used by existing gold standard methods at no loss of prediction accuracy but provides much greater throughput. The TinyHLAnet prediction engine serves as a framework for several applications, with two examples shown here: TinyHLAnet-SCAN, for proteome-wide scanning of epitopes, and TinyHLAnet-ESCAPE, for prediction of likely immune escape mutants.</p>\n </div>","PeriodicalId":13172,"journal":{"name":"HLA","volume":"106 4","pages":""},"PeriodicalIF":4.1000,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"HLA","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/tan.70410","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

CD8+ T cell response is contingent on the surveillance and recognition of peptide antigens presented on HLA class I molecules. The highly polymorphic nature of the HLA loci combined with the vast cognate peptide space makes comprehensive experimental characterisation of the peptides presented by different individuals in different disease conditions intractable. Several computational methods for epitope prediction exist, but there is a necessity in the field for rapid, interpretable and personalised prediction of CD8+ T cell epitopes. We address this gap by developing a novel deep learning architecture, termed TinyHLAnet, that produces highly accurate and fast prediction of peptide-HLA (class I) complex formation. This architecture is developed using constraints derived from domain knowledge of contact formation in peptide-HLA (class I) complexes. Specifically, the estimation of binding affinity of the peptide-HLA complex is decomposed into subproblems relating to estimating the interaction strength of each intermolecular residue pair in the complex, which in itself is factorised into three different components based on knowledge of residue pair interactions. This compartmentalisation allows for the production of a model that uses a fraction of the parameters used by existing gold standard methods at no loss of prediction accuracy but provides much greater throughput. The TinyHLAnet prediction engine serves as a framework for several applications, with two examples shown here: TinyHLAnet-SCAN, for proteome-wide scanning of epitopes, and TinyHLAnet-ESCAPE, for prediction of likely immune escape mutants.

Abstract Image

TinyHLAnet:用于CD8+ t细胞抗原快速和可解释鉴定的轻量级3D结构感知架构
CD8+ T细胞的应答取决于对HLA I类分子上呈递的肽抗原的监视和识别。HLA基因座的高度多态性与巨大的同源肽空间相结合,使得对不同个体在不同疾病条件下呈现的肽进行全面的实验表征变得困难。目前已有几种表位预测的计算方法,但该领域需要对CD8+ T细胞表位进行快速、可解释和个性化的预测。我们通过开发一种称为tinyhla的新型深度学习架构来解决这一差距,该架构可以高度准确和快速地预测肽- hla (I类)复合物的形成。这种结构是利用从肽- hla (I类)复合物中接触形成的领域知识派生的约束开发的。具体来说,肽- hla复合物结合亲和力的估计被分解为与估计复合物中每个分子间残基对相互作用强度有关的子问题,而残基对相互作用的知识本身被分解为三个不同的组成部分。这种划分允许使用现有金标准方法使用的参数的一小部分来生产模型,而不会损失预测精度,但提供了更大的吞吐量。TinyHLAnet预测引擎作为几个应用程序的框架,这里展示了两个例子:TinyHLAnet- scan,用于蛋白质组范围的表位扫描,以及TinyHLAnet- escape,用于预测可能的免疫逃逸突变体。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
HLA
HLA Immunology and Microbiology-Immunology
CiteScore
3.00
自引率
28.80%
发文量
368
期刊介绍: HLA, the journal, publishes articles on various aspects of immunogenetics. These include the immunogenetics of cell surface antigens, the ontogeny and phylogeny of the immune system, the immunogenetics of cell interactions, the functional aspects of cell surface molecules and their natural ligands, and the role of tissue antigens in immune reactions. Additionally, the journal covers experimental and clinical transplantation, the relationships between normal tissue antigens and tumor-associated antigens, the genetic control of immune response and disease susceptibility, and the biochemistry and molecular biology of alloantigens and leukocyte differentiation. Manuscripts on molecules expressed on lymphoid cells, myeloid cells, platelets, and non-lineage-restricted antigens are welcomed. Lastly, the journal focuses on the immunogenetics of histocompatibility antigens in both humans and experimental animals, including their tissue distribution, regulation, and expression in normal and malignant cells, as well as the use of antigens as markers for disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信